Please wait
0001582313N/A333-281451N/AEX-FILING FEES424B5S-300015823132026-02-272026-02-27000158231312026-02-272026-02-27xbrli:purexbrli:sharesiso4217:USD

Exhibit 107

 

 

Calculation of Filing Fee Tables

424(b)(5)
(Form Type)

Xenon Pharmaceuticals Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

 

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of
Registration Fee

Carry
Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Fees to Be Paid

Equity

Common shares, no par value per share

457(o) (1)

$400,000,000

 

$400,000,000

$138.10 per $1,000,000

$55,240.00 (1)

 —

 —

 —

 

 —

 

Carry Forward Securities

Carry Forward Securities

 

 

 

 

Total Offering Amounts

$400,000,000

$55,240.00

 (1)

Total Fees Previously Paid

 

Total Fee Offsets

 

Net Fee Due

$55,240.00

 (1)

(1)
Calculated in accordance with Rule 457(o), based on the proposed maximum aggregate offering price, and Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). This “Calculation of Filing Fee Table” shall be deemed to update the “Calculation of Filing Fee Tables” in the registrant’s Registration Statement on Form S-3ASR (File No. 333-281451), in accordance with Rules 456(b) and 457(r) under the Securities Act..